📰 Ciences News
Page 48 - Ciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.
June 5, 2023
Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple... | June 5, 2023
June 5, 2023
The Stock Day Podcast welcomed BioLargo, Inc. , a cleantech and life sciences innovator and engineering services solution provider. President and CEO of BioLargo, Inc., Dennis P. Calvert, joined Stock... | June 5, 2023
June 5, 2023
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special
June 3, 2023
Suven Life Sciences announces two poster presentations including patient baseline characteristics and demographics from the phase-2 Proof of Concept study on samelisant at... | June 3, 2023
June 3, 2023
Boston, MA - June 1, 2023 - Today, MatTek Life Sciences and AIM Biotech announced a strategic partnership through which the AIM Biotech portfolio will be available for sale through... | June 3, 2023
June 1, 2023
Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics Avacta Group plc , a life sciences company developing... | June 1, 2023
June 1, 2023
MADISON, Wis., June 1, 2023 /PRNewswire/ -- Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the... | June 1, 2023
June 1, 2023
NEW YORK and BERLIN, June 01, 2023(NASDAQ: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in upcoming June Investor
June 1, 2023
- Eight Presentations on Yescarta and TecartusAdvance Kite's Cell Therapy Leadership - - New Data Highlight Magrolimab's Potential to Alter the Tumor Microenvironment - Gilead Sciences, Inc. (Nasdaq:
June 1, 2023
NEW YORK, June 01, 2023 -- Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and... | June 1, 2023